...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Review of ZCC history

With all that has occurred with Zenith E one would expect that any BP in current clinical collboration with Zenith should be ready for a large buyout or partnership or the more conseravtive CVR deal,  I think it is only a matter of time before a deal comes through too many Billion at stakes for any of the BP's 

Share
New Message
Please login to post a reply